BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 31.05.2013

New Approaches to Antibacterial Drug Development; Request for Comments

The Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) is seeking input from the public on the following topics related to antibacterial drug development: Potential new study designs, proposed priorities for CDER guidances, and strategies intended to slow the rate of emerging resistance to antibacterial drugs. The purpose of this notice is to request information and comments from the public on these areas of focus.

Source: Federal Register — Food and Drug AdministrationOpen original release →